This is a record

Captured June 8, 2021 2:59 pm

View Mode: Standard Screenshot
View the live page
What is Perma.cc?
Title
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
Description
Original Article from The New England Journal of Medicine — Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Flag as inappropriate